Biogen (BIIB) and AbbVie (ABBV) Get Wolfe Upgrades—Which Pharma Stock Has More Upside?
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Finance & Markets
Tesla Launches the Cybercab: 2 Key Takeaways for Investors
The company is making slow but measured and deliberate progress on its Cybercab/robotaxi rollout.
Experts Explain Where The Bond Market Could Head For The Rest Of 2026
Wondering what to expect from the bond market through the remainder of 2026? Discover expert forecasts on interest rates, Treasury yields and bond portfolio strategies.
Adjusting capital gains for inflation could prove a mess for individual investors
The notion of indexing capital gains for inflation sounds attractive, but the execution could be burdensome.
Chinese Yuan: Slow appreciation with weak demand – Commerzbank
Commerzbank’s Volkmar Baur notes that Chinese growth remains export-led as domestic demand stays soft, with investment and retail sales under pressure and car sales slumping.
AST SpaceMobile vs. Redwire: Which Space Infrastructure Stock Is a Better Buy in 2026?
Both burn cash heavily, but one trades at a large valuation premium, a gap that may or may not be justified by growth potential.